Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine production. - Tu D; Lu C; Guo J; Chen Q; Li X; Wang Y; Cheng L; Jiang H; Jian J; Ge Y; Hou Z; Feng X; et al. (Clinical and molecular hepatology, 2026)